Skip to main content
Paul F. Bray, MD, Hematology, Salt Lake City, UT

Paul F. Bray MD


Professor, Medicine, Jefferson Medical College-Thos Jefferson Univ

Join to View Full Profile
  • 1950 Circle of Hope DrSalt Lake City, UT 84112

  • Phone+1 801-581-8793

Dr. Bray is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1982 - 1985
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1977 - 1980
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 1977

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Abstracts/Posters

  • The Mir-99b/Let-7e/Mir-125a cluster Is Associated with Platelet Count and Mean Platelet Volume and Regulates Megakaryocyte Proplatelet Formation
    Paul F. Bray, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Grant Support

  • MicroRNA function in human megakaryocytesNational Institutes of Health2014–Present
  • Variation In Platelet Function: The Genetics Of Platelet Gene ExpressionNational Heart, Lung, And Blood Institute2010–2012
  • Identifying Genes Regulating Platelet ReactivityNational Heart, Lung, And Blood Institute2007–2011
  • Postmenopause CHD RISK: Platelet Genes &Hormone TherapyNational Heart, Lung, And Blood Institute2006
  • Platelet, Shear Stress, And Arterial ThrombosisNational Heart, Lung, And Blood Institute2005
  • Basic And Clinical Research Training In ThrombosisNational Heart, Lung, And Blood Institute2004–2005
  • Postmenopause CHD RISK: Platelet Genes &Hormone TherapyNational Heart, Lung, And Blood Institute2003–2005
  • Genetic Basis Of Platelet HyperfunctionNational Heart, Lung, And Blood Institute2000–2004
  • Genetic Variations Affecting GP Ib-Ix/Iib-Iiia AxisNational Heart, Lung, And Blood Institute2001–2002
  • Platelet P1a2--Studies On A PRO Thrombotic PolymorphismNational Heart, Lung, And Blood Institute2000–2001
  • Mechanisms Of Arterial Thrombosis In WomenNational Heart, Lung, And Blood Institute1999
  • Platelet P1a2--Studies On A PRO Thrombotic PolymorphismNational Heart, Lung, And Blood Institute1997–1999
  • Mechanisms Of Arterial Thrombosis In WomenNational Heart, Lung, And Blood Institute1997–1999
  • In Vitro And Ex Vivo Studies On MegakaryocytopoiesisNational Heart, Lung, And Blood Institute1994–1997
  • Cellular Consequences Of Defective IIB And IIIA GenesNational Heart, Lung, And Blood Institute1990–1993
  • Biosynthesis NAD Structure Of The Fibrinogen ReceptorNational Heart, Lung, And Blood Institute1990
  • Cellular Consequences Of Defective IIB And IIIA GenesNational Heart, Lung, And Blood Institute1989
  • Biosynthesis NAD Structure Of The Fibrinogen ReceptorNational Heart, Lung, And Blood Institute1986–1989

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: